Neogenomics (NEO) EPS (Weighted Average and Diluted) (2011 - 2026)
Neogenomics (NEO) reported EPS (Weighted Average and Diluted) of -$0.13 for Q1 2026, up 35.0% on a YoY basis from -$0.1 in Q1 2025, and down 85.71% quarter-over-quarter from -$0.07 in Q4 2025.
Neogenomics (NEO) EPS (Weighted Average and Diluted) (2011 - 2026) Analysis & Trends
Neogenomics has reported EPS (Weighted Average and Diluted) for 16 years, with the latest figure at -$0.13 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 35.0% year-over-year to -$0.13; the trailing twelve-month figure through Mar 2026 stood at -$0.76 (down 24.59% YoY), and the FY2025 full-year result was -$0.84, down 35.48% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.13, down from -$0.07 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was -$0.07 in Q4 2025, with the low at -$0.4 in Q1 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.2 across 5 years, with a median of -$0.19 in 2023.
- Annual changes were most pronounced in 2022 — EPS (Weighted Average and Diluted) plunged 147.46% — and 2023, when it jumped 50.0%.
- Neogenomics' EPS (Weighted Average and Diluted) stood at -$0.18 in 2022, then soared by 38.89% to -$0.11 in 2023, then slipped by 9.09% to -$0.12 in 2024, then jumped by 41.67% to -$0.07 in 2025, then plunged by 85.71% to -$0.13 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.13 (Q1 2026), -$0.07 (Q4 2025), and -$0.21 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -0.87 |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 4.43 |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.45 |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 3.47 |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 1.20 |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -0.60 |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 1.61 |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 0.87 |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 8.33 |
| 10 | Neogenomics | 1.48 Bn | 1.33 Bn | 80.86 Mn | -0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.13 |
| Dec 31, 2025 | -0.07 |
| Sep 30, 2025 | -0.21 |
| Jun 30, 2025 | -0.35 |
| Mar 31, 2025 | -0.20 |
| Dec 31, 2024 | -0.12 |
| Sep 30, 2024 | -0.14 |
| Jun 30, 2024 | -0.15 |
| Mar 31, 2024 | -0.21 |
| Dec 31, 2023 | -0.11 |
| Sep 30, 2023 | -0.15 |
| Jun 30, 2023 | -0.19 |
| Mar 31, 2023 | -0.25 |
| Dec 31, 2022 | -0.18 |
| Sep 30, 2022 | -0.30 |
| Jun 30, 2022 | -0.28 |
| Mar 31, 2022 | -0.40 |
| Dec 31, 2021 | -0.35 |
| Sep 30, 2021 | -0.17 |
| Jun 30, 2021 | 0.59 |